Susan Bullman, Xi Chen named associate members of MD Anderson’s Allison Institute

UVA Health expands breast cancer screening with mobile 3D mammography coach

To expand access to breast cancer screening for patients across Virginia, UVA Health is rolling out a new mobile mammography coach.

February 28, 2025

Vol.51 No.08

Clinical Roundup

Breast cancer incidence, mortality cases projected to increase by 2050, study finds

A new analysis by the International Agency for Research on Cancer and collaborators evaluates the latest and future global burden of female breast cancer in about 50 countries worldwide.

February 28, 2025

Vol.51 No.08

Clinical Roundup

Researchers develop antibody-toxin conjugate to boost immune response against cancer

Researchers at the University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors.

February 28, 2025

Vol.51 No.08

Drugs & Targets

Tempus AI, Stemline Therapeutics collaborate to enhance ESR1 testing in breast cancer

Tempus AI Inc. and Stemline Therapeutics Inc. announced a new collaboration. The two companies will leverage Next—Tempus’ AI-enabled care pathway intelligence platform—to help clinicians determine when an ESR1 test may be appropriate.

February 28, 2025

Vol.51 No.08

In Brief

Charles Geyer named associate group chair of NRG Oncology

The NRG Oncology Group Chairs created the position of associate group chair and selected Charles E. Geyer to fill the position, effective immediately. He will serve alongside the three NRG Oncology group chairs, Quynh-Thu Le, Robert Mannel, and Norman Wolmark.

February 21, 2025

Vol.51 No.07

Clinical Roundup

New biomarker can predict cancer aggressiveness, study finds

Researchers from Fred Hutch Cancer Center and the University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers using a new technology and computational method.

February 21, 2025

Vol.51 No.07

Susan Bullman, Xi Chen named associate members of MD Anderson’s Allison Institute

YOU MAY BE INTERESTED IN

UVA Health expands breast cancer screening with mobile 3D mammography coach

Breast cancer incidence, mortality cases projected to increase by 2050, study finds

Researchers develop antibody-toxin conjugate to boost immune response against cancer

Tempus AI, Stemline Therapeutics collaborate to enhance ESR1 testing in breast cancer

Charles Geyer named associate group chair of NRG Oncology

New biomarker can predict cancer aggressiveness, study finds

Renew today!

Subscriber content

Never miss an issue!

Login